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A B S T R A C T
Coccidiosis in broiler chickens, caused by infection with Eimeria spp. remains one of the most economically
important production diseases. Development of a genetic biomarker panel of sub-clinical infection would be an
important biological tool for the management of broiler flocks.
We analysed expression of MicroRNAs (miRNAs) to determine the potential for these in diagnosing cocci-
diosis in broiler flocks. miRNA expression, in the ilea of Ross 308 broilers, was compared between chickens
naturally clinically or sub-clinically infected with Eimeria maxima and Eimeria acervulina using NextSeq 500
sequencing. 50 miRNAs with greatest coefficient of variance were determined and principal component analysis
showed that these miRNAs clustered within the clinical and sub-clinical groups much more closely than unin-
fected controls. Following false detection rate analysis and quantitative PCR we validated 3 miRNAs; Gallus
gallus (gga)-miR-122-5p, gga-miR-205b and gga-miR-144-3p, which may be used to diagnose sub-clinical coc-
cidiosis.
1. Introduction
Coccidiosis is one of the most economically important diseases of
chickens and significantly impacts on attempts to increase global
poultry production [5]. Coccidiosis is caused by infection of broilers
with Apicomplexan parasites of the genus Eimeria. Seven species of
Eimeria can infect chickens [2] of which three species; E. acervulina, E.
maxima and E. tenella are most commonly isolated [10]. Economic loss
in the broiler industry results from reduced feed intake and growth,
deterioration of feed efficiency and the cost of treatment [11,34,38].
Control measures routinely include the use of in-feed coccidiocidal and
coccidiostatic drugs [6] but significant resistance to these drugs has
been reported [4,6,7]. Although vaccines are available [24] their cost
and the requirement for multiple parasite lines in each vaccine have
been significant obstacles to widespread use [9,29].
Diagnosis of coccidiosis is difficult and usually relies upon the re-
cognition of site-specific enteric lesions at post-mortem [29] but dif-
ferent strains of the same Eimeria species can have varying degrees of
pathology [12]. Faecal oocyst counts can be used for diagnosis but this
is time consuming, expensive and the numbers of oocysts relate poorly
to magnitude of infection. Although PCR diagnosis of oocysts in faecal
samples has recently been reported there were significant differences
between the sensitivity of the test in detecting different Eimeria spp.
[27] and it remains to be elucidated how this diagnostic test performs
against multiple field strains of the same species. A possible diagnostic
avenue could, therefore, be to measure changes in host gene expression
during infection. It is possible that differential expression of some genes
may occur very early post-infection, which could be used to diagnose
sub-clinical disease, and it is also possible that some genes are differ-
entially expressed regardless of Eimeria species or strain.
MicroRNAs (miRNAs) are small non-coding RNAs that regulate ex-
pression of complimentary mRNA and by doing so regulate gene ex-
pression (reviewed by [3,41]). A large number of studies have high-
lighted the importance of miRNA in human disease, in particular cancer
(reviewed by [23]) and in many cases miRNA have been proposed as
novel diagnostic biomarkers of disease [16,30,31,33]. However, in
comparison to human disease, relatively little is known about miRNA
expression following disease in production animals, such as broiler
chickens.
The aim of this study was to analyse the miRNA profile in fast
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growing Ross 308 broilers naturally infected with Eimeria spp. and to
compare the miRNA profile in clinically and sub-clinically infected
flock mates. The ultimate aim was to determine a miRNA profile which
could be used to diagnose sub-clinically infected birds.
2. Methods
2.1. Ethics approval and consent to participate
Farmed broilers were obtained from routine monitoring of broiler
flocks by veterinarians with informed consent by owners. Euthanisation
of farmed broilers was performed under the guidance of national li-
censing organisations and EU directive 2010/63/EU. Euthanisation of
experimental controls was performed under the UK Animals (Scientific
Procedures) Act 1986 and were approved by the Animal Welfare and
Ethical Review Body (AWERB) of Newcastle University.
2.2. Samples
Fast growing Ross 308 broiler chickens were routinely monitored on
a Belgian farm with a history of coccidiosis. Sequencing data was de-
termined from five chickens with clinically signs of coccidiosis and five
with no clinical signs of disease and five age matched Ross 308 broilers
from an experimental facility which served as absolute negative con-
trols. Tissue sampling methods were established by a standard oper-
ating procedure (SOP) provided by the University of Nottingham
(available on request). Following necropsy, samples were immediately
placed in 5ml of RNAlater® (Life Technologies, Carlsbad, California,
USA). Samples were then dispatched to the University of Nottingham
and stored at −80 °C until further use.
2.3. Purification of total RNA
A miRNeasy kit (QIAGEN, Hamburg, Germany) was used to purify
total RNA, including miRNA, according to the manufacturer's re-
commendations. 50mg of tissue was placed in 700 μl QIAzol lysis re-
agent and then homogenised using a TissueLyser II. 140 μl chloroform
was then added and the tube was vortexed to ensure thorough mixing.
The homogenate was then incubated at room temperature for 2–3min
before it was centrifuged for 15min at 12,000 x g at 4 °C. After cen-
trifugation, the sample separated into 3 phases of which only the upper
phase containing the RNA was retained. This upper phase was trans-
ferred to a fresh collection tube and 525 μl of 100% ethanol was added.
700 μl of the sample was then transferred to an RNeasy mini spin
column in a 2ml collection tube. This was centrifuged at 8000 xg for
15 s at room temperature. The flow-through was discarded, after which
700 μl of buffer RWT was added to the column, this was centrifuged for
a further 15 s at 8000 x g. 500 μl RPE buffer was then added to the
column and centrifuged for 15 s at 8000 xg, another 500 μl of RPE
buffer was added to the column prior to centrifugation for 2min at
8000 to dry the column membrane. Finally, 50 μl RNase-free water was
then added to the column and which was centrifuged for 1min at 8000
xg to elute the RNA.
2.4. Library preparation
The library preparation was performed using the QIAseq miRNA
library kit (QIAGEN). Briefly, 500 ng of template RNA was ligated with
3′ and 5′ adapters, these adapters contained Unique Molecular
Identifiers (UMIs). Initially, the template RNA was ligated with 3′
adapters in the following reaction; 1 μl QIAseq miRNA NGS 3′ adapter,
1 μl QIAseq miRNA NGS RI, 1 μl QIAseq miRNA NGS 3′ ligase, 2 μl
QIAseq miRNA NGS 3′ buffer, 10 μl QIAseq miRNA NGS ligation acti-
vator and 5 μl template RNA. The reaction mix was incubated for 1 h at
28 °C followed by another incubation for 20min at 65 °C. The reaction
was then held at 4 °C for at least 5min. The entire reaction mix was then
used in the 5′ ligation step. Briefly, 15 μl nuclease-free water, 2 μl
QIAseq miRNA NGS 5′ buffer, 1 μl QIAseq miRNA NGS RI, 1 μl QIAseq
miRNA NGS 5′ ligase and 1 μl QIAseq miRNA NGS 5′ adapter were
added to 20 μl of the 3′ ligation reaction. This was incubated for 30min
at 28 °C followed by another incubation for 20min at 65 °C. The reac-
tion was then held at 4 °C.
2.5. cDNA synthesis
The RNA was then converted to cDNA. 2 μl QIAseq miRNA NGS RT
initiator was added to the ligated sample. The sample was then in-
cubated for 2min at 75 °C, 2min at 70 °C, 2min at 65 °C, 2min at 60 °C,
2min at 55 °C, 5min at 37 °C, 5min at 25 °C followed by indefinite
incubation at 4 °C. The reverse transcription master mix was then made
up of the following; 42 μl 5′ ligation reaction including QIAseq miRNA
NGS RT initiator, 2 μl QIAseq miRNA NGS RT primer, 2 μl nuclease-free
water, 12 μl QIAseq miRNA NGS RT buffer, 1 μl QIAseq miRNA NGS RI
and 1 μl QIAseq miRNA NGS RT enzyme. This was incubated for 1 h at
50 °C followed by another incubation for 15min at 70 °C. The samples
were then maintained for a minimum of 5min at 4 °C.
2.6. cDNA purification
The cDNA was purified by adding 143 μl QIAseq miRNA NGS beads
to the sample, which was incubated for 5min at room temperature. The
samples were then placed on a magnet stand until the beads had fully
migrated. The supernatant was discarded and the beads were kept.
While the sample was still on the magnet stand, 200 μl of 80% ethanol
was added, the ethanol was then immediately removed and discarded.
This step was repeated twice. Following the ethanol washes, the sam-
ples were air dried for 10min. The DNA was eluted by the addition of
17 μl of nuclease-free water and samples were then removed from the
magnet stand prior to resuspending the beads by pipetting. The samples
were briefly centrifuged and incubated at room temperature for 2min.
The samples were returned to the magnet stand and the beads were
allowed to migrate again. 15 μl of the eluted DNA was then transferred
to a new tube.
2.7. cDNA amplification
The cDNA was amplified using PCR (13 cycles). Briefly, 16 μl
QIAseq miRNA NGS Library buffer, 3 μl HotStarTaq DNA polymerase,
2 μl QMI TF IP1 through IP12 (index primer), QMI TF Lib Rev. Primer
was added to 15 μl of the cDNA from the previous step. The amplifi-
cation proceeded with the following steps; 15min at 95 °C, 13 cycles of
15 s at 95 °C, 30 s at 60 °C, 15 s at 72 °C, and finally one hold for 2min
at 72 °C. The samples were then incubated indefinitely at 4 °C. After
PCR the samples were purified. Following incubation for at least 5min
at 4 °C, 75 μl QIAseq miRNA NGS beads were added to the sample. The
samples were then placed on a magnet stand until the beads had fully
migrated, after which 145 μl of the supernatant was transferred to a
new tube. To the 145 μl supernatant, another 130 μl of QIAseq miRNA
Table 1
Chicken miRNAs analysed by qPCR.
miRNA name Qiagen catalogue number
gga-miR-205b YP02109153
gga-miR-2131-5p YP02105026
gga-miR-2954 YP02118706
gga-miR-144-3p YP02104164
gga-miR-31-5p YP02106253
gga-miR-122-5p YP02105332
The table show the annotated miRNA genes used in qPCR validation
and the catalogue numbers of the primer sequences required for
qPCR analysis of these genes.
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NGS beads were added. The samples were briefly vortexed and cen-
trifuged before being incubated for 5min at room temperature. The
samples were then placed on the magnet stand and the beads allowed to
fully migrate before the addition of 200 μl of 80% ethanol. The ethanol
was immediately removed and discarded. This step was repeated twice.
The samples were then air-dried for 10min and the DNA was eluted by
the addition of 17 μl of nuclease-free water. The beads were re-
suspended by pipetting followed by incubation for 2min at room
temperature. The samples were then placed on the magnet stand and
once the beads had fully migrated 15 μl of the DNA was eluted to new
tubes.
2.8. Sequencing
Library preparation QC was performed using the Bioanalyzer 2100
(Agilent, Santa Clara, California, USA). Based on the quality of the in-
serts and the concentration measurements, the libraries were pooled in
equimolar ratios. The library pool was then sequenced on a NextSeq500
sequencing instrument according to the manufacturer instructions. Raw
data was demultiplexed and FASTQ files for each sample were gener-
ated using the bcl2fastq software (Illumina inc.). FASTQ data was as-
sessed using the FastQC tool (http:// www. Bioinformatics. babraham.
ac. uk/ projects/fastqc/).
2.9. miRNA analysis
The first step of the analysis was the removal of library and se-
quencing adapters (referred to as trimming) using Cutadapt (1.11).
Trimming of adapters created a distribution of sequences with different
lengths. Reads representing miRNA had a length of ~18–23 nt, longer
sequences of other origin had a length of ~30–50 nt. During the QIAseq
miRNA library kit construction process, each individual miRNA mole-
cule was tagged with a UMI. Following sequencing and trimming, reads
were analysed for the presence of UMIs. All reads containing identical
insert sequence and UMI sequence (insert-UMI pair) were collapsed into
a single read. These reads were passed into the analysis pipeline.
Additionally, reads containing partially UMI were also passed into the
analysis pipeline. This allowed for true quantification of the miRNAs by
eliminating library amplification bias. Bowtie2 (2.2.2) was used to map
the reads. Initially a miRbase reference index was created using the
bowtie2-build command in the bowtie directory.
The mapping criteria for aligning reads to abundant sequence and
miRBase are that the reads have to perfectly match the referenceTa
bl
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Fig. 1. Reverse Transcription PCR (RT-PCR) showing sub-clinical infection with
Eimeria spp. In Ross 308 broilers.
3 Chickens from each group; clinically diagnosed natural infection, non-clinical
flock mates and uninfected (controls) were examined by agarose gel electro-
phoresis for E. acervulina, E.maxima and E. tenella DNA transcripts. The gel
shows that transcripts for E. acervulina (811 bp) and E. maxima (272 bp) were
expressed in both clinical and sub-clinical flock mates but not in uninfected
control. E. tenella DNA transcripts (538 bp) were not detected in any samples.
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sequences. After mapping the data and counting the relevant entries in
mirbase_20 the numbers of known miRNAs was calculated. The relia-
bility of the identified miRNAs increased with number of identified
fragments. When performing the statistical comparison of two groups,
we include all miRNAs irrespective of how few calls have been made.
Expression levels are measured as Tags per Million (TPM). The number
of reads for a particular miRNA is divided by the total number of
mapped reads and multiplied by 1 million. The differential expression
analysis was done using the trimmed mean of M (TMM) values in the
EdgeR statistical package (Bioconductor, http://bioconductor.org/).
Differential expression analysis on TMMs investigates the relative
change in expression (i.e. counts) between different samples and with
TMM normalization the statistical tests will be less skewed and the
false-positive rate is reduced. Note that for each differential expression
comparison, TMM is calculated, based on the subset of features and
subset of samples analysed. P-values for significantly expressed miRNAs
were estimated by an exact test on the negative binomial distribution.
2.9.1. Quantitative PCR (qPCR)
qPCR analysis was used to validate sequenced miRNAs which could
then be used to diagnose sub-clinical coccidiosis. Primer and probes
were purchased from Qiagen (primer catalogue numbers shown in
Table 1). To determine the fold change in these genes of interest a re-
ference gene was used to act as a baseline from which a ratio of in-
fected/control could be obtained. The reference miRNA genes used in
the qPCR analysis were gga-mir-140-5p and gga-mir-32-5 pm, de-
termined to be the most stable miRNAs sequenced. RNA samples were
reverse transcribed using the Applied Biosystems High Capacity cDNA
Reverse Transcriptase Kit. A master mix composed of 2.0 μl 10×RT
buffer, 0.8 μl 25× dNTP Mix (100mM), 2.0 μl 10× RT random
primers, 1.0 μl MultiScribe™ reverse transcriptase and 4.2 μl nuclease-
free H20 was added to 10 μl of RNA sample. An Applied Biosystems
2720 thermal cycler (Applied Biosystems, Foster City, California, USA)
was then programmed for the following conditions; 10min at 25 °C,
120min as 37 °C, 5min at 85 °C followed by a holding temperature of
4 °C. The resulting cDNA concentration was then quantified using a
nanodrop. A qPCR reaction was then performed using the Applied
Biosystems™ TaqMan™ Fast Advanced Master Mix. Briefly 5.0 μl of
TaqMan® Fast Advanced Master Mix (2×), 0.25 μl forward primer
(10mM), 0.25 μl reverse primer (10mM), 0.1 μl probe (10mM), 3.4 μl
nuclease-free water and 1.0 μl of cDNA (1 pg-100 ng) were mixed in a
final volume of 10 μl. For qPCR, a Roche LightCycler® 480 was used
with the following protocol; 2 min at 50 °C, 20 s at 95 °C, then 40 cycles
of 3 s at 95 °C, and 30 s at 60 °C. Analysis of the fold change between
genes was performed using the Pfaffl's method [28] and the standard
deviation (SD) was calculated using the comparative Ct method.
2.9.2. Reverse transcription PCR (RT-PCR) of Eimeria transcripts
RT-PCR was used to examine intestinal tissues from clinically di-
agnosed birds, non-clinical flock mates and uninfected control birds for
the presence of E. acervulina, E. tenella and E. maxima transcripts.
Primers (Sigma-Aldrich, Dorset, UK) and conditions for RT-PCR of
Emeria genus [26]; Primers and conditions for RT-PCR of Eimeria spe-
cies [20] are shown in Table 2. Product sizes were determined by
agarose gel electrophoresis (4% gel ran for 2 h at 80mV) and compared
to reference transcripts for each species.
3. Results
Post-mortem examination of clinically diagnosed broilers indicated
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Uninfected 19,772,462 71.5% 19.9% 2.1% 5.98%
Sub-clinical 18,353,663 71.02% 20.14% 1.28% 7.02%
Clinical 16,895,573 69.76% 21.14% 1.44% 7.24%
(E)
Fig. 2. miRNA adaptor trimming, mapping and yields.
miRNA sequencing was performed on intestinal tissues from 5 birds in each group (clinical, sub-clinical and uninfected controls). After removal of library and
sequence adaptors (trimming) the distribution of RNA reads was obtained and mean values were plotted for clinical (A) sub-clinical (B) and control (C). This
indicated that most reads were 20–24 nucleotides (nt) in length (A-C) which is the expected size for miRNA. (D) shows the mean number of reads following the
unique molecular identifier (UMI) correction process, with around 8 million mean reads, of which 25–26% were used for further analysis. (E) Following binary
alignment mapping to miRbase 20, around 70% of reads were determined to be miRNA, 20% small genomic RNA and a further 4% were outmapped or unmapped.
Average genome mapping rate was 92.8%.
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infection by E. maxima and E. acervulina via site-specific lesions. This
was confirmed by RT-PCR which also showed that flock mates with no
clinical signs were sub-clinically infected with E. maxima and E. acer-
vulina, but not E. tenella, and the absence of infection was confirmed in
the control birds (Fig. 1). Following adaptor trimming, sequence dis-
tribution peaks were around 20–24 nucleotides which is consistent with
miRNA (Fig. 2A-C). Following trimming, the reads were analysed for
the presence of UMIs. On average around 30 million raw reads were
obtained. (Fig. 2D). All reads containing identical insert sequence and
UMI sequence (insert-UMI pair) were collapsed into a single read for
further analysis, this consisted of 25–26% of the raw reads (about 8
million reads on average) (Fig. 2D). Following the clean up procedure
reported above, binary allignement mapping of RNA was performed.
This showed that around 70% of reads were miRNA, around 20% were
small genomic RNA and 1–2% outmapped (polyA and polyC homo-
polymers and rRNA and mtRNA sequences) (Fig. 2E). Only 5–7% of
sequences were unmapped, with no alignment to the RNA reference
genome (Fig. 2E).
Heat map and hierarchical clustering of the top 50 miRNAs, with
the largest variation across all samples, showed separation of samples
into clades according to clinical, sub-clinical and control status
(Fig. 3A). This was confirmed by PCA analysis, with clinical and sub-
clinical samples clustering much more closely than uninfected controls
(Fig. 3B). Following analysis of miRNA stability, we determined that
gga-mir-140-5p and gga-mir-32-5p were the most stable (Fig. 4A) and
could be used as reference genes for qPCR analysis. However, following
false detection rate analysis only 7 genes were chosen for validation by
qPCR. gga-miR-31-5p was significantly (P < .05) differentially ex-
pressed (down-regulated) only in clinically infected chickens, gga-miR-
122-5p was significantly (P < .05) differentially expressed (upregu-
lated) in both clinically and sub-clinically infected chickens and gga-
miR-205b and gga-mir-144-3p were significantly (P < .05) differen-
tially expressed only in sub-clinically infected chickens (down-regu-
lated and upregulated respectively) (Fig. 4B). We could not validate 2
of the 7 miRNAs (gga-mir-2954 and gga-mir-2131-5p) by qPCR. The
differentially expressed miRNAs in clinical and sub-clinical samples are
shown in the Venn diagram (Fig. 4C). The top 2 predicted gene targets
for each miRNA are shown in Table 3 together with target scores.
4. Discussion
Our study highlights a novel miRNA biomarker panel (gga-mir-122-
5p, gga-mir-144-5p and gga-mir-205b) which could be used to diagnose
sub-clinical coccidiosis in Ross 308 broilers, the most widely used
broiler genotype in Europe. Although very little is known about the
effect of miRNA expression in broilers, our study was not designed to
determine miRNA functionality, it was designed only to obtain a bio-
marker panel for sub-clinical coccidiosis.
We show that expression of gga-mir-122-5p was significantly up-
regulated in the intestines of Ross 308 chickens during both sub-clinical
and clinical infection with E.maxima and E. acervulina. In humans, the
orthologue of gga-mir-122-5p promotes fatty acid biosynthesis in the
liver [40] and is involved in glucose homeostasis [37], As such, gga-
mir-122-5p has been proposed as a potential biomarker of metabolic
disease and could possibly be used to predict neurological outcome
following cardiac arrest [13]. In primary chicken hepatocytes mir-122-
5p negatively regulates Vanin1, involved in gluconeogenesis and glu-
cose production [21,35] and genes involved in lipid metabolism [35].
2S   2C   1C   3S   4C   1S    5S   5U   3C   3U   5C   4S    4U  2U    1U
(A) (B)
Factor
= Uninfected control
= Clinical
= Sub-clinical
PC1
4000
2000
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-2000
-4000
-6000         
-7500       -5000            -2500                0               2500       5000
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2
Fold change in gene expression
Fig. 3. Determination of miRNA clades associated with sub-clinical infection.
The heat map (A) shows the result of two-way hierarchical clustering of genes and samples. 50 miRNAs with the highest coefficient of variation were analysed and
biological clades were detected with clinical and sub-clinical samples clustering more closely than uninfected controls. The colour scale bar shown represents an
expression level above (red) or below (green) the mean.
Principal component analysis (PCA) was also performed on the 50 miRNAs with highest co-efficient of variation (B). This also shows separation of principal
components according to the biological nature of the samples, with clinical and sub-clinical samples clustering more closely than uninfected controls. (For inter-
pretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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However, there are many other possible effects of increased gga-mir-
122-5p expression during coccidiosis as miRDB searches indicated that
there were 247 predicted gene targets for gga-mir-122-5p. A study by
Chen et al., [8] reported that inoculation of probiotic Lactobacillus
reduced inflammation in the caecum of chicks infected with Salmonella
Typhimurium and this was associated with differential expression of a
group of miRNAs including gga-mir-122-5p. This latter study also
showed that gga-miR-3525 was most significantly expressed (following
qPCR analysis) during S. Typhimurium infection but in our study, gga-
mir-3525 was not detected within the top 20 most significantly
expressed miRNAs. This may indicate that differential expression of
certain miRNAs may differentiate infectious species. A study by Ahanda
et al. [1] reported a significantly increased expression of gga-mir-122-
5p in the blood plasma of high residual feed intake (R+) chickens
compared to low residual feed intake (R-) chickens following food stress
(16 h feed deprivation). In liver tissue, gga-mir-122-5p was significantly
decreased in R+ compared to R-. Thus, indicating that genetic back-
ground influences expression of gga-mir-122-5p and it is therefore
possible that the expression of gga-mir-122-5p in the intestines of sub-
clinical and clinical Ross 308 we report may be different in other broiler
Name Stability/TPM av. Stability TPM av.
gga-miR-140-5p 0.03 16.2 577.0
gga-miR-32-5p 0.05 16.2 328.0
gga-miR-200a-5p 0.04 21.44 479.0
gga-miR-215-3p 0.1 37.33 381.0
gga-miR-1662 0.04 59.42 1411.0
gga-miR-30e-3p 0.1 64.73 666.0
gga-miR-147 0.11 75.1 678.0
gga-miR-22-3p 0.1 171.08 1704.0
gga-miR-15a 0.14 188.46 1317.0
gga-let-7g-5p 0.13 405.03 3207.0
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Fig. 4. miRNA biomarker panel of sub-clinical coccidiosis determined by quantitative PCR (qPCR).
(A) Normfinder analysis using transcripts per kilobase million (TPM) was performed to determine the 10 most stable miRNAs across the clinical, sub-clinical and
uninfected control groups. The 2 miRNAs with lowest values (gga-mir-140-5p and gga-mir-32-5p) were used as reference genes for qPCR. (B) qPCR analysis was
performed to determine expression of 7 miRNA following false detection rate analysis.
Each bar shows the mean miRNA expression in 5 birds per group performed in triplicate. Error bars show standard deviation from the mean. Asterisk (*) denotes
significant (P < .05) differential miRNA expression between clinically infected chickens and uninfected controls (black bars) or sub-clinically infected chickens and
uninfected controls (white bars). (C) Venn diagram showing the significantly expressed (P < .05) miRNA (gga-mir-122-5p and gga-mir-31-5p) in the intestines of
clinically diagnosed broilers and significantly expressed (P < .05) miRNA (gga-mir-122-5p, gga-mir-205b and gga-mir-144-3p) in the intestines of sub-clinically
infected broilers (biomarker panel of sub-clinical coccidiosis).
Table 3
The putative gene targets of miRNAs differentially expressed following qPCR analysis.
miRNA Name Accession number Sequence Predicted gene target
(score in brackets)
Protein encoded by target gene
gga-miR-122-5p MIMAT0001105 UGGAGUGUGACAAUGGUGUUUGU AKR1E2 (95)
CCNYL1 (94)
Aldo-keto reductase family 1 member E2
Cyclin Y Like 1
gga-miR-205b MIMAT0001164 CCCUUCAUUCCACCGGAAUCUG BICC1 (100)
MAG12 (99)
BicC family RNA binding protein 1
Membrane associated guanylate kinase, ww and PDZ domain
containing 2
gga-miR-144-3p MIMAT0003776 CUACAGUAUAGAUGAUGUACUC STC1 (100)
SHISA6 (100)
Stanniocalcin 1
Shisa family member 6
gga-miR-31-5p MIMAT0001189 AGGCAAGAUGUUGGCAUAGCUG N4BP2 (99)
CACNB2 (97)
NEDD4 binding protein 2
Calcium voltage-gated channel auxillary subunit beta 2
The table shows the top 2 predicted gene targets, and the proteins they encode, of the miRNAs differentially expressed in clinically diagnosed and sub-clinically
infected broilers, determined by qPCR.
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lines, for example in slower growing broilers.
Our panel also contains gga-mir-205b which, in pigeons, negatively
regulates 11β-Hydroxysteroid dehydrogenase type 1 (HSD11B1) [36].
This enzyme is believed to convert cortisone to active cortisol in vivo,
which affects blood/glucose levels and immunosuppression (reviewed
by [32]). However, in our study gga-mir-205b was significantly down-
regulated, which could prevent these effects from occurring. miRDB
searches predicted 533 target genes for gga-mir-205b. The top 2 pre-
dicted target genes were BICC1 (which encodes BicC family RNA
binding protein 1) and MAG12 (which encodes membrane associated
guanylate kinase, ww and PDZ domain containing 2). RNA binding
proteins bind RNA and influence gene expression (reviewed by [18])
and membrane associated guanylate kinases are scaffholding proteins
which anchor many different proteins, required for cell function, to cell
membranes ( [15]). However, we cannot speculate whether, or not, a
significant decrease in expression of gga-mir-205b has an effect on cell
functioning via BICC1 or MAG12.
The third miRNA we discovered to be differentially expressed in
sub-clinical samples was gga-mir-144-3p, which was significantly up-
regulated. miRDB searches predicted 1289 gene targets for gga-mir-
144-3p; with 8 of these having prediction scores of 100. These included
STC1 and SHISA6, which encode stanniocalcin 1 and shisa family
member 6 respectively. Stanniocalcin and its orthologues are involved
in homeostatic control of calcium and phosphate in fish, mammals [39]
and chickens [25], while Shisa proteins are trans-membrane tran-
scription factors which interact with fibroblast growth factor receptor
and wingless/int-1 (Wnt) receptors in mammals and birds [14,17].
Expression of gga-mir-144-3p is also upregulated in the pulmonary
artery of chickens with ascites syndrome [22] but the effect of this is
unknown. However, upregulation or down-regulation of the few mi-
croRNAs we have found could have significant biological effects due to
the high numbers of possible gene targets.
A study by Hong et al. [19] determined miRNA expression in
chicken lines resistance and susceptible to Marek's disease (line 6.2 and
7.2 respectively) in which necrotic enteritis was induced by infection
with E. maxima strain 41A, followed by Clostridium perfringens strain
DEL-1. Although the miRNA profile differed in the resistant and sus-
ceptible line, the miRNA profiles obtained in that study were very
different to that determined in our study. This could be another ex-
ample where miRNA profiling may be used to differentiate between
infectious species, since it is likely that the profile obtained by Hong
et al. [19] was dominated by the induction of necrotic enteritis rather
than coccidiosis.
In conclusion, our study has isolated a panel of miRNAs which may
differentiate sub-clinical coccidiosis from clinical coccidiosis in broiler
chickens and could, therefore, be used as an early diagnostic biomarker
of coccidiosis. However, the sensitivity and specificity of the expression
of these genes would need further investigation. The study also adds to
the growing information regarding the expression of miRNAs in pro-
duction animals.
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